4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-028517
CEO and CFO bought 3,000 shares at $9.75 ($29,250)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-10-14 | Purchase | +3,000 | $9.75 | $29,250 | 2,719,886 | D |
| Open-market purchases · 3,000 sh · avg $9.75 · $29,250 | |||||||
Loading xslF345X03/ownership.xml…